Covered recipient · General Payments record
KRISTEN MARIE SIRACUSE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,018.97
- Reported across 51 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $392.77 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $217.83 | 10 |
| Myriad Genetic Laboratories, Inc. | $59.01 | 3 |
| Ferring Pharmaceuticals Inc. | $58.81 | 2 |
| ACCORD HEALTHCARE, INC. | $19.33 | 1 |
| UROGEN PHARMA, INC. | $19.16 | 1 |
| Sumitomo Pharma America, Inc. | $18.63 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.92 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205384 | CMS |
| ABBVIE INC. | $22.48 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205386 | CMS |
| ABBVIE INC. | $26.68 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205388 | CMS |
| ABBVIE INC. | $17.51 | 03/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205390 | CMS |
| ABBVIE INC. | $1.38 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205392 | CMS |
| ABBVIE INC. | $27.89 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205394 | CMS |
| ABBVIE INC. | $24.27 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205396 | CMS |
| ABBVIE INC. | $26.94 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205398 | CMS |
| ABBVIE INC. | $24.48 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205400 | CMS |
| ABBVIE INC. | $21.28 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108205402 | CMS |
| ACCORD HEALTHCARE, INC. | $19.33 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1120083572 | CMS |
| Ferring Pharmaceuticals Inc. | $33.99 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137544680 | CMS |
| Ferring Pharmaceuticals Inc. | $24.82 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137544684 | CMS |
| Myriad Genetic Laboratories, Inc. | $22.54 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152551072 | CMS |
| Myriad Genetic Laboratories, Inc. | $17.30 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152551074 | CMS |
| Myriad Genetic Laboratories, Inc. | $19.17 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152551076 | CMS |
| Sumitomo Pharma America, Inc. | $18.63 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148995392 | CMS |
| UROGEN PHARMA, INC. | $19.16 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137918001 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.